ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 32.51% | 25.86% | 25.99% | 17.78% | 12.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.51% | 25.86% | 25.99% | 17.78% | 12.83% |
| Cost of Revenue | 32.24% | 18.90% | 22.32% | 16.39% | 10.17% |
| Gross Profit | 32.68% | 30.41% | 28.32% | 18.67% | 14.57% |
| SG&A Expenses | 40.27% | 37.11% | 23.67% | 17.74% | 17.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.77% | 27.20% | 21.10% | 16.06% | 15.95% |
| Operating Income | -33.15% | -29.18% | -13.83% | -13.33% | -21.01% |
| Income Before Tax | -56.42% | -55.80% | -39.67% | -34.83% | -27.72% |
| Income Tax Expenses | -257.89% | -172.00% | 200.00% | 358.33% | -56.82% |
| Earnings from Continuing Operations | -56.16% | -55.54% | -39.78% | -35.03% | -27.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.16% | -55.54% | -39.78% | -35.03% | -27.51% |
| EBIT | -33.15% | -29.18% | -13.83% | -13.33% | -21.01% |
| EBITDA | -32.23% | -30.40% | -13.27% | -14.54% | -22.76% |
| EPS Basic | -46.39% | -47.12% | -33.66% | -28.93% | -19.54% |
| Normalized Basic EPS | -39.11% | -39.55% | -25.22% | -19.79% | -19.72% |
| EPS Diluted | -46.39% | -47.12% | -33.66% | -28.93% | -19.54% |
| Normalized Diluted EPS | -39.11% | -39.55% | -25.22% | -19.79% | -19.72% |
| Average Basic Shares Outstanding | 6.74% | 5.24% | 4.27% | 4.76% | 6.52% |
| Average Diluted Shares Outstanding | 6.74% | 5.24% | 4.27% | 4.76% | 6.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |